Indication

Osteoporosis

Osteoporosis is a systemic skeletal disorder characterized by low bone mass, deterioration of bone microarchitecture, and increased bone fragility. Read more about Osteoporosis

323 drugs 93 manufacturers

Advertisement

Drugs that treat it

Common Osteoporosis therapies.

Showing 109–117 of 323 drugs

Filter & compare in the drug finder →Opens the drug finder with Osteoporosis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Osteoporosis.

Osteoporosis is a systemic skeletal disorder characterized by low bone mass, deterioration of bone microarchitecture, and increased bone fragility.

Although it can affect individuals of any age or sex, it most commonly arises in postmenopausal women and older adults due to age-related bone loss, estrogen deficiency, or secondary causes such as chronic glucocorticoid therapy and endocrine disorders.

Pathophysiologically, an imbalance where osteoclast-mediated bone resorption outpaces osteoblast-mediated bone formation leads to diminished bone mineral density and compromised mechanical strength.

Often clinically silent until a low-energy trauma occurs, it predisposes patients to pathological fragility fractures, most frequently involving the spine, hip, and wrist.

Personalize your experience

Follow Osteoporosis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it